NCT07156422 Pathophysiological Study of the Sensitive Scalp
| NCT ID | NCT07156422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Sensitive Scalp |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-28 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-28 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sensitive skin is defined as a syndrome manifested by the occurrence of unpleasant sensations (tingling, burning, pain, pins and needles) in response to stimuli that should not normally cause them. These unpleasant sensations cannot be explained by lesions attributable to a specific skin disease. Sensitive skin can affect different parts of the body. The scalp is a site that is often affected, with specificity linked in particular to the presence of hair and different triggering factors (styling habits, wearing of head coverings, application of cosmetics to the scalp, etc.). Sensitive scalp affects around half the population, and can have an impact on the quality of life of sufferers, particularly those whose symptoms are very intense. Women are more likely than men to have a sensitive scalp, so in order to have a more homogenous study population, we chose to include 40 women. The pathophysiology of sensitive skin is imperfectly understood, and studies specific to the sensitive scalp are very rare. However, the pathophysiology of the sensitive scalp could be different because it is a hairy area, more innervated, and less exposed to environmental factors.
Eligibility Criteria
Inclusion Criteria: * Adult women without dermatosis * Collection of free and informed consent * patient affiliated to a social security scheme For the control group: Sensiscalp score = 0/20 Sensitive scalp group: Sensiscalp score ≥ 3/20 with pruritus sensation ≥ 2/20 Exclusion Criteria: * Refusal to take part in the study * Dermatosis of the scalp (psoriasis, seborrhoeic dermatitis, etc.) * Pregnant and breast-feeding women * Women under legal protection (guardianship, curatorship)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07156422 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Sensitive Scalp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07156422 currently recruiting?
Yes, NCT07156422 is actively recruiting participants. Contact the research team at emilie.brenaut@chu-brest.fr for enrollment information.
Where is the NCT07156422 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT07156422 clinical trial?
NCT07156422 is sponsored by University Hospital, Brest. The trial plans to enroll 40 participants.